3D-QSAR Studies of Some [[1-Aryl(or Benzyl)-1-(benzenesulphonamido)methyl] phenyl] Alkanoic Acid Derivatives as Thromboxane A2 Receptor Antagonists

References

• Halmos, T., Turek, J. W., Breton, G. C. Le., and Autonakis, K. (1999). Synthesis and biological characterization of sqabazide. A novel biotinylated photoaffinity probe for the human platelet thromboxane A2 receptor. Bioorg. Med. Chem. Lett., 9, 2963-2968.
   PubMed Web of Science ®Google Scholar
• Ogletree, M. L. (1987). Overview of physiological and patho-physiological effects of thromboxane A2. Fed. Proc. Fed. Am. Soc. Exp. Biol., 46, 133–138.
   PubMedGoogle Scholar
• Hall, S. E. (1991). Thromboxane A2 receptor antagonists. Med. Res. Rev., 11, 503–579.
   PubMed Web of Science ®Google Scholar
• Schrör, K., and Thiemermann, C. (1988). Treatment of acute myocardial ischemia with a selective antagonist of thromboxane receptor (BM 13.177). Br. J. Pharmacol., 87, 631–637.
   Web of Science ®Google Scholar
• Thiemermann, C., Ney, P., and Schrör, K. (1988). The thromboxane receptor antagonist, daltroban, protects the myocardium from ischemic injury resulting in suppression of leukocytosis. Eur. J. Pharmacol., 155,57-67.
   Web of Science ®Google Scholar
• Arimura, A., Asanuma, F., Kurosawa, A., and Harada, M. (1992). Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pigs. Int. Arch. Allergy Immunol., 98, 239–246.
   PubMed Web of Science ®Google Scholar
• Perzborn, E., Seuter, F., Fiedler, V. B., Rosentreter, U., and Böshagen, H. (1989). Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulphonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid on vascular smooth muscle preparations. Arzneim.-Forsch./Drug Res., 39, 1522–1525.
   PubMed Web of Science ®Google Scholar
• Tomiyama, T., Yakota, M., Wakabayashi, S., Kosakai, K., and Yanagisawa, T. (1993). Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulphonates and related compounds: Non-prostanoid thromboxane A2 receptor antagonists. J. Med. Chem., 36, 791.
   PubMed Web of Science ®Google Scholar
• Sukurai, S., Ohawa, N., Suzuki, T., Kato, K., Ohashi, T., Yasuda, S., Kato, H., and Ito, Y. (1996). Synthesis and thromboxane A2 antagonist activity of [[1-ary1(or benzyl)-1-(benzenesulphonamido)methyl] phenyl] alkanoic acid derivatives. Chem. Pharm. Bull., 44, 765–777.
   PubMed Web of Science ®Google Scholar
• Stewart, J. J. P. (1990). MOPAC: A Semiempirical molecular orbital program. J. Comput. Aided Mol. Des., 4,1-105.
   Web of Science ®Google Scholar
• Dewar, M. J. S., Zoebish, E. G., Healy, E. F., and Stewart, J. J. P. (1985). AM1, A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc., 107, 3902.
   Web of Science ®Google Scholar
• Rohrbaugh, R. H., and Jurs, P. C. (1987). Descriptors of molecular shape applied in studies of structure/activity and structure/property relationships. Analytica Chimica Acta, 199, 99–109.
   Web of Science ®Google Scholar
• Rogers, D., and Hopfinger, A. J. (1994). Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure property relationships. J. Chem. Inf. Comput. Sci., 34, 854–866.
   Google Scholar
• Cerius2. A program suite for molecular modelling activities, Molecular Simulations Inc., Scranton Road, San Diego, CA 92121-3752, USA.
   Google Scholar
• Sakurai, S., Ogawa, N., Onogi, Y., Takeshita, M., Takahashi, H., Ohashi, T., Kato, K., and Kato, H. (1997). Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulphonamido)alkyl]-phenyl]alkanoic acid derivatives. Chem. Pharm. Bull., 45, 849-862.
   PubMed Web of Science ®Google Scholar
• Stanton, D. T., and Jurs, P. C. (1990). Development and use of charge partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies. Anal. Chem., 62, 2323–2329.
   Web of Science ®Google Scholar
• a) Hahn, M. (1995). Receptor surface models. 1. Definition and construction. J. Med. Chem., 38, 2080–2090. b) Hahn, M., and Rogers, D. (1995). Receptor surface models. 2. Application to quantitative structure-activity relationship studies. J. Med. Chem., 38, 2091–2102.
   PubMed Web of Science ®Google Scholar